AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. Co.'s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the antibody discovery problems. Co. has developed technology platforms to unlock drug classes, targets, and modalities, including transmembrane proteins, T-cell engagers, and peptide-MHCs. Co. is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two preclinical programs in its internal pipeline are ABCL575 and ABCL635. We show 15 historical shares outstanding datapoints in our ABCL shares outstanding history coverage, used to compute ABCL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABCL market cap history over the course of time is important for investors
interested in comparing ABCL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABCL versus a peer is one thing; comparing
ABCL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABCL can fluctuate over the course of history.
With this page we aim to empower investors researching ABCL by allowing them to research the ABCL market cap history. |
Free ABCL Email Alerts:
Video: The Importance of Market Cap
